Wolters Kluwer Names Chris Sullivan Vice President of Business Segment for Clinical Effectiveness | Company

WALTHAM, Mass.–(BUSINESS WIRE)–Sept. 21, 2022–

Wolters Kluwer, Healthcare, today announced the appointment of Christopher Sullivan as Vice President and Commercial Segment General Manager for Clinical Effectiveness.

During his 11 years at Wolters Kluwer, Sullivan held various leadership positions in the areas of strategy, product management, pricing and strategic partnerships. Most recently, he served as Vice President and General Manager of Transactional and Pension Portfolio in the Legal and Regulatory Division of Wolters Kluwer, where he oversaw a portfolio of SaaS solutions and expert content serving professionals. of law and compliance.

In his new role, Sullivan will lead the business segment with responsibility for setting strategy and driving growth for its clinical decision support (CDS) solutions, including Medi-Span®, Lexicomp®, UpToDate® and Emmi®. . The segment provides expert content and workflow tools to professionals in the pharmacy, digital health technology and commercial payer markets. Sullivan reports to Greg Samios, President and Chief Clinical Effectiveness Officer, Wolters Kluwer, Healthcare.

“Expanding our footprint in the commercial market is a critical part of our overall strategy,” said Samios. “With his strong background and proven track record at Wolters Kluwer, I’m confident Chris will expand our business footprint as we accelerate the development of impactful solutions for our customers.”

“I am honored to lead the commercial segment as we increase investment in the business,” Sullivan said. “These are pivotal times in healthcare – our portfolio is the lifeblood of clinicians around the world, and we are committed to helping our clients achieve better outcomes, faster.”

Prior to joining Wolters Kluwer, Sullivan held various operations management positions at DHL. He received an MBA from Fordham University and a BS from the United States Military Academy at West Point.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for clinicians, nurses, accountants, lawyers and tax, finance, auditing, risk, compliance and regulation. We help our customers make critical decisions every day by delivering expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer achieved annual sales of €4.6 billion in 2020. The group serves customers in over 180 countries, maintains operations in over 40 countries and employs around 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes in healthcare. We support clinical efficiency, learning and research, clinical monitoring and compliance, and data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information visit www.wolterskluwer.com, follow us on TwitterFacebook, LinkedIn and YouTube.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220921005261/en/

CONTACT: Media:

Andre Rebelo

Senior Global Public Relations Manager

Wolters Kluwer Health

+1 (781) 392-2411

[email protected]

KEYWORD: MASSACHUSETTS EUROPE UNITED STATES NETHERLANDS NORTH AMERICA

INDUSTRY KEYWORD: HEALTH SCIENCE PHARMACEUTICAL RESEARCH HEALTH TECHNOLOGY

SOURCE: Wolters Kluwer Health

Copyright BusinessWire 2022.

PUBLISHED: 09/21/2022 09:51 / DISK: 09/21/2022 09:51

http://www.businesswire.com/news/home/20220921005261/en

Copyright BusinessWire 2022.

Sara H. Byrd